logo
Secret messages on Luxor Obelisk in Paris finally decoded

Secret messages on Luxor Obelisk in Paris finally decoded

Independent02-05-2025

Secret hieroglyphics on the 3,300-year-old Luxor Obelisk in Paris, commissioned by Ramesses II, have been decoded.
Egyptologist Jean-Guillaume Olette-Pelletier's research suggests the inscriptions are propaganda praising Ramesses II as divinely chosen to rule Egypt.
The obelisk's western side, originally facing the Nile, positioned the inscriptions for optimal viewing from boats.
Deciphered messages reveal Ramesses II making offerings to the god Amun and pronouncements of his divine essence and eternal life.
Dr. Olette-Pelletier's study highlights three-dimensional cryptography, where messages vary based on viewing angle, but awaits peer review and further analysis regarding visibility from the Nile.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Birmingham firm secures £1 million to develop STI rapid test
Birmingham firm secures £1 million to develop STI rapid test

South Wales Argus

time6 days ago

  • South Wales Argus

Birmingham firm secures £1 million to develop STI rapid test

Birmingham-based Linear Diagnostics has secured £1 million in funding to develop the technology, which could deliver results in less than 20 minutes. The funding comes from the NIHR Invention for Innovation programme and will support a three-year project to finalise the test and prepare it for clinical trials. Dr Jean-Louis Duprey, head of research and development at Linear Diagnostics, said: "We are developing a near patient device that will overcome this conundrum." The company is working with the NIHR HealthTech Research Centre and the North East Innovation Lab to deliver the project. Dr Jana Suklan, senior methodologist at the HRC, said: "The NIHR HRC in Diagnostic and Technology Evaluation is delighted to be collaborating with the North East Innovation Lab to support Linear Diagnostics with their exciting technology. "Our research involves analysing unmet needs, examining current practice and identifying the most promising point in the patient pathway for implementing the technology." The test uses Linear's Exponential Amplification (EXPAR) technology, which detects bacterial DNA within minutes. The company has focused on STIs such as Neisseria gonorrhoeae and Chlamydia trachomatis, where rapid diagnosis is essential to prevent further transmission and begin treatment immediately.

Secret messages on Luxor Obelisk in Paris finally decoded
Secret messages on Luxor Obelisk in Paris finally decoded

The Independent

time02-05-2025

  • The Independent

Secret messages on Luxor Obelisk in Paris finally decoded

Secret hieroglyphics on the 3,300-year-old Luxor Obelisk in Paris, commissioned by Ramesses II, have been decoded. Egyptologist Jean-Guillaume Olette-Pelletier's research suggests the inscriptions are propaganda praising Ramesses II as divinely chosen to rule Egypt. The obelisk's western side, originally facing the Nile, positioned the inscriptions for optimal viewing from boats. Deciphered messages reveal Ramesses II making offerings to the god Amun and pronouncements of his divine essence and eternal life. Dr. Olette-Pelletier's study highlights three-dimensional cryptography, where messages vary based on viewing angle, but awaits peer review and further analysis regarding visibility from the Nile.

Merck KGaA to replace two executives with company veterans
Merck KGaA to replace two executives with company veterans

Reuters

time18-02-2025

  • Reuters

Merck KGaA to replace two executives with company veterans

FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA ( opens new tab said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added that its strategy remains unchanged. Jean-Charles Wirth is to become the CEO of the Life Science unit, a maker of gear and supplies for biotech labs, succeeding Matthias Heinzel, who has decided to not renew his contract. Wirth currently heads the Science & Lab Solutions subunit within Life Science, the company said in a statement. Danny Bar-Zohar, currently the head of drug research and development, will become CEO of the pharmaceuticals division, succeeding Peter Guenter, who has decided to retire from Merck, it added. In addition, Khadija Ben Hammada will assume the newly created role of Chief People Officer on March 1, as Merck adds a sixth executive board seat. She currently holds the title of Chief Human Resources Officer and will take on additional responsibilities in areas such as sustainability, compliance and site management of the headquarters in Darmstadt. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store